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Amplification of gene expression of the most productive colony type of Amycolatopsis mediterranei 
strain N1 under stress of chloramphenicol, resulted in isolation of a variant NCH with productivity of 
2.56 g/l compared to 1.15 g/l by the parent strain N1 (2.2 fold increase) . This amplified variant has a 
further advantage of reduced variation in colony morphology with predominance of the most productive 
colony type. Using variant NCH, modification of the fermentation medium F1 by the addition of 0.1%  
yeast extract or the use of 1.8% KNO3  resulted in 3.8 and 5.8-fold increase in productivity, respectively, 
compared to  strain N1. When the F1 medium was replaced by a new medium F2 containing soytone, 
instead of the particulate constituents (peanut meal and soybean meal) the yield by variant NCH 
reached 7.85 g/l (6.8-fold increase). Modification of the F2 medium by addition of glycerol or the 
replacement of glucose by glucose syrup decreased rifamycin B production. Changing the 
concentration of soytone increased the yield only slightly while replacing it with peptone or tryptone or 
the addition of 1 % corn steep liquor failed to increase the yield. On the other hand, the addition of 0.1 
% yeast extract, or the replacement of 0.6% (NH4)2SO4 by 1.2% KNO3 or 0.4% NH4NO3,  to F2 medium led 
to 8.2, 10.2 and 10.4-fold increase in productivity, respectively, compared to productivity of strain N1 in 
F1 medium. The change in the concentrations of either MgSO4 or CaCO3, the use of different types of 
antifoams and the use of higher concentrations  of sodium diethyl barbiturate did not significantly 
influence the yield. These collective optimization attempts thus resulted in a 10.4-fold increase in 
productivity, from 1.15 to 11.99 g/l. 
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Attempts have been made to improve fermentation and 
downstream processing parameters for better yieds of 
rifamycins. Continuous efforts since 1960 have led to the 
development of several industrial strains of 
Amycolatopsis mediterranei either with the ability to 
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that could directly produce active rifamycins and their 
derivatives (Chiao et al., 1988; Lal et al., 1995; Lancini 
and Hengeller, 1971; Lysko and Gorskaia, 1986; 
Ghisalba et al., 1982; Schupp and Divers 1986). Gene 
amplification is of widespread occurrence in prokaryotic 
and eukaryotic organisms (Anderson and Roth,1977; 
Schimke et al., 1982) where selection for increased gene 
dosage can be applied to generate strains that carry 
multiple copies of a gene and consequently high gene 
expression products (Young,1984). 
Biotechnology production processes are the result of 
time-consuming, expensive research. For each producing  




strain, the medium and the other process parameters 
must be adjusted to allow the maximal expression of the 
producing capacity. It is obvious that such informations 
are industrial properties, and for rifamycin, the 
composition of the media actually used for industrial 
production are not published. However, some information 
can be extrapolated from published laboratory data and 
patent literature that give a fairly good idea of the most 
suitable ingredients and their concentrations (Lancini and 
Cavalleri, 1997; Pape and Rehm, 1985). 
Our previous attempts to improve rifamycin B 
productivity of the industrial strain N1 by selection of the 
best producing colony type and by modifying the 
fermentation medium F1 resulted in an increase in the 
yield from 0.5 to 2.92 g/l (El-Tayeb et al., 2004). This is 
much lower than the economically viable yield. Therefore, 
in this study, we tried two approaches: the improvement 
of the producer strain by gene amplification and studying 
different physiological parameters for the process 
including media constituents. 
 
 




A. mediterranei – RCP 1001 mutant strain N1 was obtained from El-





Chemicals used throughout this work were of laboratory reagent 
grade unless otherwise indicated. Glucose, KNO3, NH4NO3, NaNO2 
and propylene glycol were the products of ADWIC, Egypt. Sodium 
diethyl barbiturate (SDB) was the product of Grindstedvaerket A/S, 
Denmark. Potassium sodium tartarate tetrahydrate, 
3,5_dinitrosalicylic acid, CaCO3, MgSO4.7H2O, FeSO4.7H2O, 
KH2PO4, ZnSO4.7H2O, CoCl2.6H2O, (NH4)2SO4 and NaOH were the 
products of E. Merck, Darmstadt, Germany. Glacial acetic acid was 
the product of Aldrich Ltd, England. Chloramphenicol was obtained 
from Chemical Industries Development Co. (CID), Egypt.  





Tryptone, peptone, yeast extract, malt extract, beef extract, skim 
milk, soytone, and bacto agar were the products of Difco 
Laboratories, Detroit, U.S.A. Corn steep liquor and glucose syrup 
were obtained from the Egyptian Co. for Manufacture of Starch and 
Glucose, Egypt. Oat flakes, soybean meal and peanut meal were 
obtained from local commercial suppliers. 
Media used for propagation, selection and maintenance as well 
as the vegetative medium V1 and the fermentation medium F1 
were those previously reported by El-Tayeb et al. (2004). The 
vegetative medium V2 (Lee and Rho, 1994) is composed of: 
glucose, 20.0 g; yeast extract, 5.0 g; tryptone, 2.5 g; malt extract, 
5.0 g and distilled water to 1000.0 ml. The pH of was adjusted to 
7.0.  The fermentation medium F2 (Lee and Rho, 1994) is 
composed of: dextrose, 120.0 g; soytone, 35.0 g; (NH4)2SO4, 6.0 g; 
KH2PO4, 1.0 g; CaCO3, 8.5 g; MgSO4.7H2O, 0.8 g; sodium diethyl 
barbiturate, 1.0 g and distilled water to 1000.0 ml. The pH was 
adjusted to 7.1.  






The methods used for maintenance, propagation, selection, 
preparation of inoculum and production of rifamycin B in shake 
flasks as well as determination of remaining glucose concentration 
and assay of rifamycin B were those previously reported by El-
Tayeb et al. (2004). Yields of rifamycin B indicated are those 
obtained on day 8, unless otherwise indicated.The biomass was 






Gene amplification was carried out as described by Kallio et al. 
(1987). A 5% v/v inoculum of strain N1 was added to a flask 
containing 100 ml vegetative medium (V1) containing 15 µg/ml 
chloramphenicol. The shake flask was incubated for 3 days at 
28°C. One ml of this culture was used to inoculate another flask 
containing 30 µg/ml of the antibiotic, then the shake flask was 
incubated for 3 days at 28°C and the procedure was repeated using 
60 µg/ml chloramphenicol. Several aliquots of 1 ml of the last 
culture were transferred onto the surface of Bennett’s agar plates 
containing 120 µg/ml chloramphenicol. These plates were 
incubated for 12 –15 days at 28°C. Typical colonies (El-Tayeb et 
al., 2004) were selected and cultured onto the surface of Q/2 agar 
slants, incubated for 8 days at 28°C and used for propagation and 
selection. The variant obtained, NCH, was maintained as 





The variant NCH  was compared to strain N1 for 
productivity in F1 medium (Figure 1) whereby it produced 
2.56 g/l compared to 1.15 g/l by strain N1. The pattern of 
productivity by both cultures was somewhat similar, with 
variant NCH showing higher slope of increase between 
days 6 and 8. Both sugar consumption and pH were 
similar with both strains. The variant NCH showed the 
same colonial morphology and microscopical 
characteristics as the parent strain N1 on Bennett’s agar 
and F1 medium. However, it showed less variation in 
colony morphology with the predominence of the best 
productive colony type.    
Modification of the F1 medium was carried out by the 
addition of yeast extract and by changing the 
concentrations of each of glucose and KH2PO4 as well as 
replacing (NH4)2SO4 by KNO3 (Figure 2). Addition of 0.1% 
yeast extract after 2 days of incubation increased 
rifamycin B production from 2.56 to 4.32 g/l (68%), while 
the use of 0.9 and 1.8% KNO3 markedly increased 
rifamycin B production from 2.56 to 6.33 g/l (2.5-fold) and 
to 6.72 g/l (2.6-fold), respectively. Upon microscopical 
examination, It was observed that KNO3 decreased 
branching and fragmentation of the mycelia in the 
fermentation medium. On the other hand, the use of 
glucose in concentrations above or below 14% (control) 
reduced the yield by 15-17% (Figure 2). In addition, the 
use of KH2PO4 in concentrations above 0.1% (control) 
caused a marked decrease (37-45%) in the yield (Figure 






















Figure 1. Comparison between strain N1 and variant NCH with 
respect to rifamycin B production (P), remaining glucose 




























Figure 2. Effect of different modifications in F1 medium on 




process using variant NCH resulted in a significant 
increase in the yield from 2.56 g/l to a maximum of 6.72 
g/l (2.6-fold).  
To further increase the yield of rifamycin B using 
variant NCH, we resorted to radical modification of both 
the vegetative and the fermentation media. In  addition  to  
























Figure 3. Comparison between F1 and F2 media with respect to 
rifamycin B production (P), remaining glucose concentration (S), 




failing to reach the desired yield, F1 medium was a 
particulate medium in which following biomass production 
was not possible through either dry cell weight or 
turbidity. We thus shifted to a soluble medium, F2. It was 
thought appropriate then to also shift the vegetative 
medium to a particle free one, V2. This approach resulted 
in an increase of rifamycin B production from 2.56 to 7.85 
g/l (3.1-fold) when compared to production by variant 
NCH on unmodified F1 medium (Figure 3). Using F2 
medium we noted that while biomass formation started 
immediately and reached its peak after 4 days, 
production started only on day 2 and reached its 
maximum on day 8. 
Further optimization of rifamycin B production by the 
variant NCH in F2 medium included changes of most of 
its ingredients, their concentrations and the time of their 
addition and the results are presented in Table 1. In all 
cases, rifamycin B production, remaining glucose 
concentration, biomass and pH were followed in a time 
course. The carbon sources glucose syrup and glycerol, 
the nitrogen sources peptone, tryptone, corn steep liquor, 
soytone at a concentration of less than 3% and 
concentrations of (NH4)2SO4 as well as different 
concentrations of MgSO4 and CaCO3 failed to increase 
the yield (Table 1 and Figures 4 and 5). Different 
concentrations of SDB and different types of antifoam 
gave comparable yields (Table 1). On the other hand, the 
addition of 0.1 % yeast extract after 2 days of incubation 
(Table 1) increased the yield from 7.85 to 9.49 g/l (21%) 
and the replacement of (NH4)2SO4 with 0.6 to1.2% KNO3  
or with 0.05 to 0.8% NH4NO3, increased rifamycin B 













































P (N1) P (NCH)
S (N1) S (NCH)






















control 0.1% yeast extract added after 2 days
0.9% KNO3 instead of (NH4)2SO4 1.8% KNO3 instead of (NH4)2SO4
12% glucose 16% glucose
























   




































(P) F1 (P) F2 (S) F1 (S) F2
(X) F2 (pH) F1 (pH) F2




             Table 1. Effect of different modifications in F2 medium* on rifamycin B production by variant NCH on day 8. 
 
Variable factors Conc. 
(g%) 
Rifamycin B 
  conc. (g/l) 
Variable factors Conc. 
(g%) 
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Low density            
   silicone oil 
High density  















*The concentrations of the F2 medium (control) are between brackets. 
(1) Glycerol added after 1 day of incubation. 
(2) Glycerol added after 3 days of incubation. 
(3) Instead of glucose. 
(4) Instead of (NH4)2SO4. 
(5) Instead of soytone. 
(6) Yeast extract added after 2 days of incubation. 
(7) Corn steep liquor added after 1 day of incubation. 
(8) Sodium diethyl barbiturate. 
 
 
KNO3 or 0.4% NH4NO3 which increased the yield from 
7.85 to 11.76  (50%) and 11.99 g/l (53%), respectively 





Although our previous optimization attempts to improve 
the fermentation process using strain N1 in F1 medium 
increased rifamycin B production, the yield was too low to 
be used for an economically viable technology and some 
variation in colony types continued to be observed (El-
Tayeb et al., 2004). To obtain higher yields and to 
overcome the problem of variation in colony types, 
another approach to improve the strain had to be tried. 
Gene amplification as a method of strain improvement 
had been successfully used with Bacillus subtilis 
producing α-amylase (EL-Tayeb et al., 2000; Kallio et al., 
1987). By application of gene amplification to N1 strain 
(by   exposing   the   parent   strain    N1    to    increasing  









































Figure 4. Effect of replacing glucose with different concentrations of glucose syrup in F2 medium on rifamycin B 




concentrations of chloramphenicol), we achieved 2.2-fold 
higher yield (Figure 1) with less colony variation and 
predominance of the most productive colony type.  
The increase in the production of rifamycin B after 
treatment of the parent strain with chloramphenicol could 
be explained by the finding of Lenski et al. (1994) that 
repeated subculture of a plasmid–containing strain under 
selective conditions eventually gave rise to a variant of 
the plasmid that was much more stable in the absence of 
selection than the original form of the plasmid. Salyers 
and Amabile-Cuevas (1997) suggested that exposure of 
a bacterium with a newly acquired plasmid or conjugative 
transposon to antibiotic concentrations high enough to be 
slightly selective but low enough to allow bacteria to 
replicate could foster adaptive mutations that have the 
effect of fixing the element in its new host. They further 
suggested that any gene carried on the plasmid would 
have the chance during this period of selective pressure 
to increase their expression levels or to adopt to a better 
fit with their new host. On the basis of the above 
explanations, one may suspect the possible presence of 
plasmids in colony type 1 which are involved in the 
biosynthesis of rifamycin. Although Ghisalba et al. (1984) 
reported that no plasmids have been isolated from 
Nocardia mediterranei ATCC 13685 and its mutants and 
indicated that plasmids do not play a significant role in 
rifamycin biosynthesis, a genetically manipulated 
industrial strain such as strain N1 may show different 
genomic constitution.  However, it should also be noted 
that, Kallio et al. (1987) studied α-amylase production by 
Bacillus subtilis in two different gene expression systems 

















































































































Figure 5. Effect of addition of 6% glycerol after 1 or 3 days and of 
1% corn steep layer after 1 day to F2 medium on rifamycin 





























Figure 6. Effect of replacing (NH4)2SO4 with KNO3 in F2 medium on 
rifamycin B production (P), remaining glucose concentration (S) and 
pH by variant NCH. 
 
 
plasmid or in the chromosome. They found that gene 
amplification by chloramphenicol resulted in higher 





for α-amylase than in plasmid containing or the parental 
strains. Further genetic studies on variant NCH are 
needed in order to determine whether the amplification of 
the gene for rifamycin B biosynthesis is plasmid or/and 
chromosomally encoded. 
Optimization of the process using variant NCH in F1 
medium by the addition of yeast extract, changing 
concentrations of either glucose or KH2PO4 or replacing 
(NH4)2SO4 by KNO3 gave  results which were similar to 
those previously obtained with strain N1 ((El-Tayeb et al., 
2004). When glucose concentrations above or below the 
control were used the yield decreased by 15–17% 
(Figure 2).  In conclusion, optimization of rifamycin B 
production by variant NCH using a modified F1 medium 
increased the yield from 2.56 g/l to a maximum of 6.72 g/l 
(2.6-fold). 
To further increase the yield of rifamycin B we shifted to 
soluble media, V2 and F2, recommended by Lee and 
Rho (1994). This approach resulted in a 3.1-fold increase 
of rifamycin B yield by variant NCH from 2.56 to 7.85 g/l 
as compared to production in the unmodified F1 medium. 
This increase in the yield was associated with a marked 
increase in the apparent rate of glucose consumption till 
day 4 along with a decrease in pH from day 2 to day 4 
(Figure 3). After day 4, the apparent rate of glucose 
consumption decreased, with F2 medium, along with a 
rise in pH from 6.5 to 7.7 while higher remaining glucose 
concentration was still available with F1 medium. The rise 
in pH after day 4 is possibly due to the disappearance of 
carbohydrates and the metabolism of the intermediate 
organic acids accumulated, as well as the slow release 
and metabolism of nitrogenous materials from proteins. 
Lee et al. (1983) concluded that the utilization of glucose 
at the idiophase is an influencing factor for rifamycin B 
production, since almost all the carbon units in the 
rifamycin B molecule are derived from glucose. They 
added that the optimal pH condition in the idiophase was 
found to be in the range of pH 7.0 to 7.5. 
 Further attempts to optimize rifamycin B production by 
variant NCH in F2 medium were carried out by changing 
most of its ingredients, their concentrations and the time 
of their additions. The fermentation process lasts for 8 
days and a consistent lag time of about 48 h was 
observed before the beginning of antibiotic production. 
Ghisalba et al. (1984) mentioned that the long lag phase 
observed during the fermentation of A. mediterranei is 
one of the problems encountered in rifamycin B 
production. However, they did not give any suggestion as 
to how this problem may be overcome.  
Replacing glucose with the less expensive glucose 
syrup (5-30%) decreased the yield. The use of 5, 10 and 
15% glucose syrup decreased biomass till day 5 and 
consequently antibiotic production by 19  to 22% along 
with high pH values (above 7.5) in the trophophase 
(Figure 4). Taking into consideration that the glucose 
syrup used was prepared by acid hydrolysis of starch and 







































(P) control  (P) glycerol, day 1 (P) glycerol, day 3
(P) corn steep liquor (X) control (X) glycerol, day1 
(X) glycerol, day3 (X) corn steep liquor (pH) control 






















   

























(P) control (P) 0.6% KNO3 (P) 1.2% KNO3
(P) 1.8% KNO3 (S) control (S) 0.6% KNO3
(S) 1.2% KNO3 (S) 1.8% KNO3 (pH) control





content of glucose, this rise in pH may point to a possible 
establishment of a critical balance in utilization of 
glucose, dextrins, and amino acids released from soluble 
proteins of the medium as energy sources with dextrins 
being least favored. With such possibility, a slight rise of 
pH could be expected as a result of release of ammonia 
from amino acids along with continuous consumption of 
intermediate organic acids produced during metabolic 
activity. However, the higher concentrations of glucose 
syrup (20-30%) markedly decreased the yield by 55 to 
82%. It is possible that these high concentrations of 
glucose syrup might contain some undesirable 
ingredients such as hydroxy-methyl furfural, which led to 
inhibition of rifamycin B biosynthesis even though the 
results do not suggest inhibition of biomass production 
(Figure 4). It is interesting that with all the tested 
concentrations of glucose syrup, the pattern of remaining 
reducing sugars was somewhat similar and differed from 
the control, showing a slower rate of carbohydrate 
utilization. It seems that the organism continuously 
replenishes the reducing sugars by hydrolysing more 
higher saccharides. 
Since A. mediterranei can utilize either glucose or 
glycerate as a precursor for the biosynthesis of 3-amino-
5-hydroxybenzoic acid which is the chain initiator 
molecule in the biosynthesis of rifamycins (White et al., 
1974), we used a supplement of 6% glycerol to the F2 
medium containing 12% glucose after 1 or 3 days of 
incubation (Figure 5). The addition of glycerol after 1 day 
was associated with reduced biomass during the 
idiophase with somewhat lower rifamycin B production, 
while its addition after 3 days led to a similar reduction in 
biomass but the yield was comparable to the control.  
As for the content of organic nitrogen sources in F2 
medium, the soytone concentrations of 3% and higher 
gave comparable rifamycin B production while lower 
concentrations resulted in some reduction of the yield 
(Table 1).  Replacement of soytone by other 
enzymatically hydrolyzed proteins such as tryptone and 
peptone (Table 1) slightly decreased the yield. The 
addition of 0.1% yeast extract after 2 days increased the 
antibiotic yield by 21% (Table 1). In contrast, the use of 
1% corn steep liquor after 1 day decreased the yield 
along with a marked decrease in pH during the idiophase, 
while the biomass was comparable to the control (Figure 
5). Yeast extract here is regarded more as a source of 
cofactors than of nitrogen nutrients. In one sense corn 
steep liquor is a comparable substrate. However, since it 
did not produce the same effect one may assume that 
corn steep liquor acts as a nitrgen source but not as a 
source of stimulatory cofactors such as the B-factor 
present in yeast extract (Kawaguchi et al., 1984, 1988). 
This conclusion should be taken in conjunction with the 
observed lower pH which corn steep liquor produced 
after day 4 which is not favorable for antibiotic production 
(Lee et al., 1983). In this respect, Krishna et al. (2000) 
reported that some organic  nitrogen  compounds  do  not  




stimulate rifamycin SV production because of feed back 
effects which are strain specific. As for inorganic nitrogen 
sources, 0.4% (NH4)2SO4 led to a rifamycin B yield 
comparable to the control (0.6%), while higher 
concentrations (0.8–1%) resulted in a slight reduction in 
yield (Table 1). Lee and Rho (1994) suggested that the 
use of high concentrations of ammonium ion repressed 
rifamycin B production.  
Since nitrate stimulates rifamycin production by its 
regulatory effect on lipid and rifamycin biosynthetic 
pathways (Rui_Shen et al., 1979), we replaced (NH4)2SO4 
in F2 medium with different concentrations of KNO3 and 
NH4NO3 .The use of 0.6, 0.9 and 1.2% KNO3 in F2 
medium, led to an increase in rifamycin B production by 
12, 13 and 50%, respectively (Table 1 and Figure 6). It is 
to be noted that 1.2% KNO3 contains an equivalent 
nitrogen as 0.6% (NH4)2SO4 present in F2 medium 
(control). A similar increase has been previously 
observed when using KNO3 in F1 medium with variant 
NCH (Figure 2) and strain N1 (EL-Tayeb et al., 2004). In 
contrast, the use of 1.8% KNO3 led to 42% decrease in 
rifamycin B production, along with an increase in pH 
observed all over the time course of the fermentation, 
which also affected growth. 
When (NH4)2SO4 was replaced by 0.05-0.8% NH4NO3 
(Table 1) rifamycin B production increased from 7.85 g/l 
to a maximum yield of 11.99 g/l (53%). All the tested 
concentrations also showed almost the same pattern of 
glucose consumption and of biomass production but 
slight differences in pH patterns.  This is in contrast with 
the findings of Lysko and Gorskaia (1986) who tested 
different inorganic nitrogen sources, and found that 
(NH4)2SO4 but not NH4NO3, NH4Cl and NaNO3 provided 
optimum pH levels for antibiotic production. This 
disagreement may be due to differences in strains, since 
Rui_Shen et al. (1979) reported that some strains did not 
utilize nitrate as a nitrogen source and that the effect of 
nitrate is strain specific. 
Although SDB was reported to act as an activator or an 
inhibitor of certain enzymes associated with rifamycin B 
production, causing a shift toward the production of 
rifamycin B (Lal et al., 1995; Mejia et al., 1998), 
concentrations of SDB above that present in F2 medium 
(0.1%) slightly increased the yield of rifamycin B (Table 
1). Similarly, changes in concentrations of MgSO4 and 
CaCO3 did not cause a major shift in antibiotic yield 
(Table 1). Since antifoams, which are necessary when 
the process is conducted in a stirred tank fermentor, may 
affect growth and consequently antibiotic production, 
different types of antifoams namely, low and high density 
silicone oils and sunflower oil were tested. They all 
resulted in comparable antibiotic yields (Table 1).  
In conclusion, the application of gene amplification 
technique increased rifamycin B production from 1.15 to 
2.56 g/l (2.2- fold) and reduced morphological colony 
variation. Modification of the fermentation medium F1 
increased the yield from 2.56 to 6.72 g/l  (2.6-fold).  When  




the V1 and the F1 media were radically replaced by V2 
and F2 media, the yield increased from 2.56 to 7.85 g/l 
(3.1-fold). Modification of the F2 medium by the addition 
of 0.1% yeast extract after 2 days of incubation or the use 
of either 1.2% KNO3  or 0.4% NH4NO3, instead of 
(NH4)2SO4,  increased the yield from 7.85  to  9.49, 11.76 
and 11.99 g/l, respectively. These yields are promising 
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